Hengrui Pharma Adds 0.20 Million Shares to Treasury for ESOP, Spending RMB 9.45 Million

Bulletin Express06-05 16:53

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) disclosed a repurchase of 200,000 A-shares on 4 June 2026 via the Shanghai Stock Exchange for its A-Share Employee Stock Ownership Schemes.

• Transaction details – Shares repurchased: 200,000 – Volume-weighted average price: RMB 47.27 per share – Price range: RMB 47.05–47.45 – Aggregate consideration: RMB 9.45 million

• Capital structure impact (5 June 2026 closing balance) – Issued shares outstanding fell to 6,371.49 million, down 0.0031 % from the previous day. – Treasury shares rose to 7.52 million. – Total issued shares remained unchanged at 6,379.00 million, as the repurchased shares were shifted to treasury rather than cancelled.

Board authorisation and all regulatory requirements under the Hong Kong and Shanghai listing rules were confirmed as satisfied.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1165700052?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-05 16:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1165700052","market":"hk","top_or_hot":-1,"title":"Hengrui Pharma Adds 0.20 Million Shares to Treasury for ESOP, Spending RMB 9.45 Million","media":"Bulletin Express","content":"<p>Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) disclosed a repurchase of 200,000 A-shares on 4 June 2026 via the Shanghai Stock Exchange for its A-Share Employee Stock Ownership Schemes.</p>\n<p>• Transaction details  \n  – Shares repurchased: 200,000  \n  – Volume-weighted average price: RMB 47.27 per share  \n  – Price range: RMB 47.05–47.45  \n  – Aggregate consideration: RMB 9.45 million</p>\n<p>• Capital structure impact (5 June 2026 closing balance)  \n  – Issued shares outstanding fell to 6,371.49 million, down 0.0031 % from the previous day.  \n  – Treasury shares rose to 7.52 million.  \n  – Total issued shares remained unchanged at 6,379.00 million, as the repurchased shares were shifted to treasury rather than cancelled.</p>\n<p>Board authorisation and all regulatory requirements under the Hong Kong and Shanghai listing rules were confirmed as satisfied.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hengrui Pharma Adds 0.20 Million Shares to Treasury for ESOP, Spending RMB 9.45 Million</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHengrui Pharma Adds 0.20 Million Shares to Treasury for ESOP, Spending RMB 9.45 Million\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-06-05 16:53</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) disclosed a repurchase of 200,000 A-shares on 4 June 2026 via the Shanghai Stock Exchange for its A-Share Employee Stock Ownership Schemes.</p>\n<p>• Transaction details  \n  – Shares repurchased: 200,000  \n  – Volume-weighted average price: RMB 47.27 per share  \n  – Price range: RMB 47.05–47.45  \n  – Aggregate consideration: RMB 9.45 million</p>\n<p>• Capital structure impact (5 June 2026 closing balance)  \n  – Issued shares outstanding fell to 6,371.49 million, down 0.0031 % from the previous day.  \n  – Treasury shares rose to 7.52 million.  \n  – Total issued shares remained unchanged at 6,379.00 million, as the repurchased shares were shifted to treasury rather than cancelled.</p>\n<p>Board authorisation and all regulatory requirements under the Hong Kong and Shanghai listing rules were confirmed as satisfied.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01276","symbol_name":"恒瑞医药","start_time":0,"source_url":"","article_id":"1165700052","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1165700052","pubTimestamp":1780649582,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) disclosed a repurchase of 200,000 A-shares on 4 June 2026 via the Shanghai Stock Exchange for its A-Share Employee Stock Ownership Schemes....","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01276":"恒瑞医药"},"translate_title":"恒瑞医药为ESOP增持0.20万股入库，耗资945万元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01276":1},"content_text":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) disclosed a repurchase of 200,000 A-shares on 4 June 2026 via the Shanghai Stock Exchange for its A-Share Employee Stock Ownership Schemes.\n• Transaction details  \n  – Shares repurchased: 200,000  \n  – Volume-weighted average price: RMB 47.27 per share  \n  – Price range: RMB 47.05–47.45  \n  – Aggregate consideration: RMB 9.45 million\n• Capital structure impact (5 June 2026 closing balance)  \n  – Issued shares outstanding fell to 6,371.49 million, down 0.0031 % from the previous day.  \n  – Treasury shares rose to 7.52 million.  \n  – Total issued shares remained unchanged at 6,379.00 million, as the repurchased shares were shifted to treasury rather than cancelled.\nBoard authorisation and all regulatory requirements under the Hong Kong and Shanghai listing rules were confirmed as satisfied.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1165700052","isCrawlerRequest":true}